Guy, Holly
Laskier, Vicki
Fisher, Mark
Neuman, W. Richey
Bucior, Iwona
Deitelzweig, Steven
Cohen, Alexander T.
Funding for this research was provided by:
Portola Pharmaceuticals, Inc.
Article History
First Online: 21 December 2018
Compliance with Ethical Standards
:
: HG, VL, and MF are employees of FIECON Ltd, a health-economics outcomes research agency, which performed the analyses presented in the manuscript, funded by Portola Pharmaceuticals, Inc. WRN and IB are employees of Portola Pharmaceuticals, Inc. SD has received consulting fees or honoraria, fees for provision of medicines, equipment, or administrative support, and payment for lectures from Portola Pharmaceuticals, Inc, Pfizer, Janssen and BMS. SD has received support for travel to meetings from Portola Pharmaceuticals, Inc and fees for expert testimony from Janssen. ATC has received consulting fees, research support, and honoraria from AbbVie, ACI Clinical, Aspen, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Boston Scientific, CSL Behring, Daiichi-Sankyo, GlaxoSmithKline, GLG, Guidepoint Global, Johnson and Johnson, Leo Pharma, Medscape, McKinsey, Navigant, ONO, Pfizer, Portola Pharmaceuticals, Inc, Sanofi, Takeda, Temasek Capital, and TRN.
: This analysis was supported by Portola Pharmaceuticals, Inc.
: For this type of study, formal consent is not required.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.